![Dannielle Appelhans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dannielle Appelhans
Director/Board Member at
HALOZYME THERAPEUTICS, INC.
Profile
Ms. Dannielle Appelhans is a President, Chief Executive Officer & Director at Cour Pharmaceuticals Development Co., Inc. She is on the Board of Directors at Halozyme Therapeutics, Inc. and Cour Pharmaceuticals Development Co., Inc. Ms. Appelhans was previously employed as an Independent Director by Generation Bio Co., a President & Chief Executive Officer by VL26, INC., a Chief Technical Officer by AveXis, Inc., and a Senior Manager-Engagement by McKinsey & Co., Inc. She received her undergraduate degree from the University of Michigan, a graduate degree from Massachusetts Institute of Technology and an MBA from MIT Sloan School of Management.
Dannielle Appelhans active positions
| Companies | Position | Start |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director/Board Member | 2026-08-13 |
Cour Pharmaceuticals Development Co., Inc.
 Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Chief Executive Officer | 2024-08-31 |
Former positions of Dannielle Appelhans
| Companies | Position | End |
|---|---|---|
| GENERATION BIO CO. | Director/Board Member | 2026-02-05 |
| RUBIUS THERAPEUTICS | Chief Executive Officer | 2023-03-02 |
| AVEXIS INC | Chief Tech/Sci/R&D Officer | 2020-12-31 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 2014-11-30 |
Training of Dannielle Appelhans
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
- Stock Market
- Insiders
- Dannielle Appelhans
